Abstract |
In a crossover study conducted over a six-month period in eight patients with well-characterized premenstrual syndrome, physical and behavioral symptoms were relieved by daily administration of an agonist of gonadotropin-releasing hormone. The reversible "medical ovariectomy" attained with this agonist suggests that it may be an effective and rational treatment for this distressing syndrome in the short term. Whether prolonged therapy would be safe and effective, or even necessary, remains to be determined.
|
Authors | K N Muse, N S Cetel, L A Futterman, S C Yen |
Journal | The New England journal of medicine
(N Engl J Med)
Vol. 311
Issue 21
Pg. 1345-9
(Nov 22 1984)
ISSN: 0028-4793 [Print] United States |
PMID | 6387488
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Hormones
- Triptorelin Pamoate
- Gonadotropin-Releasing Hormone
- Tryptal
|
Topics |
- Adult
- Clinical Trials as Topic
- Female
- Gonadotropin-Releasing Hormone
(analogs & derivatives, pharmacology, therapeutic use)
- Hormones
(pharmacology, therapeutic use)
- Humans
- Menstruation
(drug effects)
- Premenstrual Syndrome
(drug therapy)
- Syndrome
- Triptorelin Pamoate
(analogs & derivatives)
|